Davies, PD, Brown, RC, Woodhead, JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax
1985; 40: 187–190.
Nnoaham, K, Clarke, A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. International Journal of Epidemiology
2008; 37: 113–119.
Gibney, KB, et al.
Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from Sub-Saharan Africa. Clinical Infectious Diseases
2008; 46: 443–446.
Ho-Pham, L, et al.
Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. BMC Infectious Diseases
2010; 10: 306.
Wejse, C, et al.
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. American Journal Respiratory Critical Care Medicine
2009; 179: 843–850.
Martineau, AR, et al.
High-dose vitamin D (3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet
2011; 377: 242–250.
Salahuddin, N, et al.
Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infectious Diseases
2013; 13: 22.
Ralph, AP, et al.
L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, placebo-controlled trial. PLoS ONE
2013; 8: e70032.
Nielsen, NO, et al.
Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. British Journal of Nutrition
2010; 104: 1487–1491.
Mack, U, et al.
LTBI: latent tuberculosis infection or lasting immune response to M. tuberculosis? A TBNET consensus statement. European Respiratory Journal
2009; 33: 956–973.
Bailey, WC, et al.
Predictive model to identify positive tuberculosis skin test results during contact investigations. Journal of the American Medical Association
2002; 287: 996–1002.
Arnedo-Pena, A, et al.
Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study. BMC Infectious Diseases
2011; 11: 349.
Ganmaa, D, et al.
Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. American Journal of Clinical Nutrition
2012; 96: 391–396.
Task Group on Tuberculosis. National consensus on the control of tuberculosis in spain. Medicina Clinica (Barcelona)
1992; 98: 24–31.
Zwerling, A, et al.
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability. PLoS ONE
2013: 8: e54748.
Gran, G, Abmus, J, Dyrhol-Riise, AM. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results. BMC Public Health
2013; 13: 353.
Cluse, ZN, et al.
Evaluation of 25-hidroxy vitamin D assay on the immunodiagnostic systems iSYS analyser. Annals Clinical Biochemistry
2012; 49: 159–165.
Holick, MF.Vitamin D deficiency. New England Journal of Medicine
2007; 357: 266–281.
Rockhill, B, Newman, B, Weinberg, C. Use and misuse of population attributable fractions. American Journal of Public Health
1998: 88: 15–19.
Talat, N, et al.
Vitamin D deficiency and tuberculosis progression. Emerging Infectious Diseases
2010; 16: 853–855.
Sudfeld, C, et al.
Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. Journal of Infectious Diseases
2013; 207: 378–385.
Wingfield, T, et al.
The seasonality of tuberculosis, sunlight, vitamin D, and household crowding. Journal of Infectious Diseases. Published online: 4 March 2014. doi:10.1093/injdis/jiu121.
Rosen, CJ. Vitamin D insufficiency. New England Journal of Medicine
2011; 364: 248–254.
Aloia, J. Clinical Review: The 2011 report on dietary reference intake for vitamin D: Where do we go from here?
Journal of Clinical Endocrinology and Metabolism
2011; 96: 2897–2996.
Dini, C, Bianchi, A. The potential role of vitamin D for the prevention and treatment of tuberculosis and infectious diseases. Annali dell'Istituto Superiore di Sanità
2012; 48: 319–327.
Hewison, M. Antibacterial effects of Vitamin D. Nature Reviews Endocrinology
2011; 7: 337–345.
Liu, PT, et al.
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science
2006; 311: 1770–1773.
Fabri, M, et al.
Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Science Translational Medicine
2011; 3: 104ra102.
Liu, PT, et al.
Convergence of IL-1β and VDR activation pathways in humans TLR 2/1 induced antimicrobial responses. PLoS ONE
2009; 4: e5810
Lin, PL, Flynn, JL. Understanding latent tuberculosis: a moving target. Journal of Immunology
2010; 185: 15–22.
Greenstein, RJ, Su, L, Brown, ST. Vitamins A and D inhibit the growth of Mycobacteria in radiometric culture. PLoS ONE
2012; 7: e29631.
Fox, GJ, et al.
Contact investigation for tuberculosis: a systematic review and meta-analysis. European Respiratory Journal
2013; 41: 140–156.
Cailleaux-Cezar, M, et al.
Tuberculosis incidence among contacts of active pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease
2009; 13: 190–195
Goris-Pereiras, A, et al.
Factors predicting new tuberculosis infections and tuberculin conversions in a contact tracing system.
2008; 18: 183–189.
Hill, P, et al.
Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS ONE
2007; 1: e183.
Farrell, CJ, et al.
State-of-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clinical Chemistry
2012; 58: 531–542.
Nienhaus, A, et al.
IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers. Expert Review of Anti-Infective Therapy
2013; 11: 37–48.
Van Zyl-Smit, RN, et al.
Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE
2009; 4: e8517.
Verrall, AJ, et al.
Early clearance of Mycobacterium tuberculosis: a new frontier in prevention. Immunology
2014; 141: 506–513.